tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
Holding SBFM?
Track your performance easily

Sunshine Biopharma (SBFM) Financial Statements

332 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently ―. The company's EPS TTM is $-155.585; its P/E ratio is -0.02; Sunshine Biopharma is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $256.00. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 8.44M$ 9.30M$ 7.54M$ 7.68M$ 5.96M
Gross Profit$ 2.87M$ 2.36M$ 2.35M$ 2.57M$ 1.99M
EBIT$ -982.59K$ -837.75K$ -1.21M$ -999.65K$ -572.00K
EBITDA$ -982.59K$ -837.75K$ -1.17M$ -957.29K$ -572.00K
Net Income Common Stockholders$ -1.20M$ -494.30K$ -1.28M$ -1.25M$ -651.48K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.21M$ 11.51M$ 17.43M$ 16.29M$ 18.85M
Total Assets$ 30.06M$ 29.30M$ 31.90M$ 27.35M$ 27.65M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -12.21M$ -11.51M$ -17.43M$ -16.29M$ -18.85M
Total Liabilities$ 5.02M$ 5.81M$ 7.08M$ 6.14M$ 5.69M
Stockholders Equity$ 25.04M$ 23.49M$ 24.82M$ 21.21M$ 21.96M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow--$ -3.19M--
Investing Cash Flow--$ -668.74K--
Financing Cash Flow--$ 5.40M--
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Sunshine Biopharma Debt to Assets

Sunshine Biopharma Cash Flow

Sunshine Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis